Trial Profile
Treatment of Progressive Forms of Multiple Sclerosis With Pulsed ACTH (Acthar Gel)
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 18 May 2023
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 12 May 2023 Status changed from active, no longer recruiting to discontinued.
- 02 Aug 2022 Planned End Date changed from 30 Jun 2022 to 31 Dec 2022.
- 02 Aug 2022 Planned primary completion date changed from 30 Jun 2022 to 31 Dec 2022.